Rixubis Recommended by EMA Panel for Hemophilia BRixubis Recommended by EMA Panel for Hemophilia B

Rixubis has been recommended by the European Medicines Agency's Committee for Medicinal Products for Human Use for prophylaxis and treatment of bleeding in patients with hemophilia B. International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news